跳至主要内容
临床试验/NCT02034942
NCT02034942已完成不适用

Substudy of Non-Seda Trial (NCT01967680): Non-sedation Versus Sedation With a Daily Wake-up Trial in Critically Ill Patients Receiving Mechanical Ventilation - Effects on Physical Function. An Investigator-initiated, Randomised, Clinical, Parallel-group, Multinational, Superiority Trial

Palle Toft1 个研究点 分布在 1 个国家目标入组 205 人开始时间: 2014年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
205
试验地点
1
主要终点
Physical function

研究概览

简要总结

Critically ill, ventilator-treated patients rapidly loose much of their muscle mass and strength. This can attribute to prolonged admission, prolonged mechanical ventilation, increased mortality and might have a negative impact on the physical function, degree of independence and quality of life. The pathophysiological background for the loss of muscle mass as well as possible effective treatment is still not well established. In the NONSEDA-trial we randomise critically ill patients to non-sedation or sedation with a daily wake-up trial during mechanical ventilation in the intensive care unit (ICU). It has never been assessed whether non-sedation reduces the loss of muscle mass and strength.

Aim: To assess the effects of non-sedation versus sedation with a daily wake-up trial on physical function after discharge from ICU.

Hypothesis: that non-sedation during ventilator-treatment will improve the physical function after ICU-discharge, compared with standard treatment of sedation with a daily wake-up.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Endotracheally intubated
  • •Expected time on ventilator > 24 hours
  • •Age ≥ 18 years
  • •Informed consent

排除标准

  • •Severe head trauma where therapeutic coma is indicated
  • •Therapeutic hypothermia where therapeutic coma is indicated
  • •Status epilepticus where therapeutic coma is indicated
  • •Patient has participated in the study before
  • •Patient is transferred from another ICU with length of stay > 48 hours
  • •Patient is comatose at admission
  • •PaO2/FiO2 ≤ 9, if sedation is necessary for oxygenation

研究组 & 干预措施

Non-sedation

Experimental

The experimental group will not receive sedatives. Patients are thoroughly and repeatedly informed by the staff of where they are, what have happened, and what type of treatment they are going to receive.

Participants will be awake and have a natural sleep rhythm. In case these patients develop and outward delirium, it is necessary to have a nurse or other caregiver at the bedside in order to calm the patient. Patients with delirium will be treated with haloperidol.

干预措施: Non-sedation (Other)

Sedation with daily wake-up

Active Comparator

The control group will be sedated to Ramsay score 3-4. The first 48 hours the patients will be sedated with propofol, after 48 hours midazolam will be used. During daytime, the patient will be awakened as the intravenous infusion of sedatives will be discontinued. The patient will be considered to be awake when he/she can perform at least three of the following four tasks:

  • Open the eyes to verbal commands.
  • Follow the examiner's instructions with the eyes.
  • Squeeze hands on request.
  • Stick out the tongue on request.

After a successful wake-up, the infusion of sedative will be resumed, starting on half of the pre-wake-up dose and adjusted to Ramsey score 3-4.

干预措施: Sedation, control (Other)

结局指标

主要结局

Physical function

时间窗: 3 months after ICU-discharge

Co-primary outcome of: patient-reported quality of life, as measured by SF-36v2, physical component and degree of independence in activities of daily living, as measured by Barthel Index. Since this is a co-primary outcome, the type I error probability associated with the test of the null hypothesis should be less than 0,025.

次要结局

  • Handgrip(3 months after ICU-discharge)
  • Thigh muscle size(3 months after ICU-discharge)
  • Biomechanical data(3 months after ICU-discharge)
  • 6 minute walk(3 months after ICU-discharge)

研究者

发起方
Palle Toft
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Palle Toft

Professor

Odense University Hospital

研究点 (1)

Loading locations...

相似试验